首页> 外文期刊>The Journal of Physiology >RGS2 blocks slow muscarinic inhibition of N-type Ca(2+) channels reconstituted in a human cell line.
【24h】

RGS2 blocks slow muscarinic inhibition of N-type Ca(2+) channels reconstituted in a human cell line.

机译:RGS2阻止慢毒蕈碱抑制人类细胞系中重构的N型Ca(2+)通道。

获取原文
获取原文并翻译 | 示例
           

摘要

1. Native N-type Ca(2+) channels undergo sustained inhibition through a slowly activating pathway linked to M1 muscarinic acetylcholine receptors and Galphaq/11 proteins. Little is known concerning the regulation of this slow inhibitory pathway. We have reconstituted slow muscarinic inhibition of N-type channels in HEK293 cells (a human embryonic kidney cell line) by coexpressing cloned alpha1B (Ca(V)2.2) Ca(2+) channel subunits and M1 receptors. Expressed Ca(2+) currents were recorded using standard whole-cell, ruptured-patch techniques. 2. Rapid application of carbachol produced two kinetically distinct components of Ca(2+) channel inhibition. The fast component of inhibition had a time constant of < 1 s, whereas the slow component had a time constant of 5-40 s. Neither component of inhibition was reduced by pertussis toxin (PTX) or staurosporine. 3. The fast component of inhibition was selectively blocked by the Gbetagamma-binding region of beta-adrenergic receptor kinase 1, suggesting that fast inhibition is mediated by Gbetagamma released from Galphaq/11. 4. The slow component of inhibition was selectively blocked by regulator of G protein signalling 2 (RGS2), which preferentially interacts with Galphaq/11 proteins. RGS2 also attenuated channel inhibition produced by intracellular dialysis with non-hydrolysable GTPgammaS. Together these results suggest that RGS2 selectively blocked slow inhibition by functioning as an effector antagonist, rather than as a GTPase-accelerating protein (GAP). 5. These experiments demonstrate that slow muscarinic inhibition of N-type Ca(2+) channels can be reconstituted in non-neuronal cells, and that RGS2 can selectively block slow muscarinic inhibition while leaving fast muscarinic inhibition intact. These results identify RGS2 as a potential physiological regulator of the slow muscarinic pathway.
机译:1.本地N型Ca(2+)通道通过与M1毒蕈碱乙酰胆碱受体和Galphaq / 11蛋白相连的缓慢激活途径持续抑制。关于这种缓慢抑制途径的调控知之甚少。我们通过共表达克隆的alpha1B(Ca(V)2.2)Ca(2+)通道亚基和M1受体,重构了HEK293细胞(人类胚胎肾细胞系)中N型通道的缓慢毒蕈碱抑制。表达的Ca(2+)电流是使用标准的全细胞,破裂膜片技术记录的。 2.快速应用卡巴胆碱产生Ca(2+)通道抑制的两个动力学上不同的组件。抑制的快速成分的时间常数<1 s,而抑制缓慢的成分的时间常数为5-40 s。百日咳毒素(PTX)或星形孢菌素均不能减少抑制作用。 3.抑制的快速成分被β-肾上腺素能受体激酶1的Gbetagamma结合区域选择性地阻断,这表明快速抑制是由Galphaq / 11释放的Gbetagamma介导的。 4.抑制的缓慢成分被G蛋白信号传导2(RGS2)的调节剂选择性地阻断,后者优先与Galphaq / 11蛋白相互作用。 RGS2还减弱了使用不可水解的GTPgammaS进行细胞内透析所产生的通道抑制作用。这些结果共同表明,RGS2通过充当效应拮抗剂而不是GTPase促进蛋白(GAP)来选择性地阻断缓慢抑制。 5.这些实验表明,在非神经元细胞中可以重构N型Ca(2+)通道的毒蕈碱抑制作用缓慢,而RGS2可以选择性地阻断毒蕈碱抑制作用,而保留完整的毒蕈碱抑制作用。这些结果确定RGS2作为慢毒蕈碱途径的潜在生理调节剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号